TFEB and neoplasm: LncRNA XXYLT1-AS2, highly expressed in HCC plasma, promotes tumor growth by inhibiting autophagy and enhancing proliferation, migration, and invasion of HCC cells, through the degradation of TFEB via the ubiquitin proteasome pathway.